Preface |
|
v | |
|
|
|
|
|
|
|
|
Contributors |
|
ix | |
PART I Endothelium and Biology of Nitric Oxide |
|
|
Discovery of Endothelium-Derived Relaxing Factor and Its Identification as Nitric Oxide |
|
|
3 | (10) |
|
|
|
|
|
Discovery of Biological Roles of Nitric Oxide in the Cardiovascular System |
|
|
13 | (16) |
|
|
|
|
|
|
|
|
|
Molecular Mechanisms of Intracellular Endothelium Nitric Oxide Regulation |
|
|
29 | (8) |
|
|
|
|
|
|
|
|
|
Cardiovascular Effects of Nitric Oxide: Lessons Learned from Endothelial Nitric Oxide Synthase Knockout Mice |
|
|
37 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Nitric Oxide Signaling Mediating Relaxation of Vascular Smooth Muscle |
|
|
49 | (8) |
|
|
|
|
|
Hemoglobin-Bound Nitric Oxide Participates in the Mammalian Respiratory Cycle |
|
|
57 | (8) |
|
|
|
|
|
|
|
|
|
Hormonal Regulation of Endothelium-Derived Factors |
|
|
65 | (14) |
|
|
|
|
PART II Basic Mechanisms of Endothelial Dysfunction |
|
|
Endothelial Dysfunction and Vascular Disease |
|
|
79 | (18) |
|
|
|
|
|
Endothelium-Derived Constricting Factors and Endothelial Dysfunction |
|
|
97 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Endothelial Nitric Oxide and Vascular Inflammation |
|
|
119 | (14) |
|
|
|
|
|
Vascular Oxidant Stress and Nitric Oxide Bioactivity |
|
|
133 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
PART III Clinical Studies of Endothelial Function and Dysfunction |
|
|
Endothelium, Nitric Oxide, and Hypertension |
|
|
147 | (16) |
|
|
|
|
|
Nitric Oxide Availability in Hypercholesterolemia |
|
|
163 | (22) |
|
|
|
|
|
Nitric Oxide Activity in the Human Coronary Circulation |
|
|
185 | (12) |
|
|
|
|
|
Endothelial Vasodilator Dysfunction in Chronic Heart Failure |
|
|
197 | (16) |
|
|
|
|
|
|
|
|
|
In Vitro Studies of the Human Microcirculation in Cardiovascular Disorders |
|
|
213 | (14) |
|
|
|
|
PART IV Therapeutic Strategies to Improve Endothelial Dysfunction |
|
|
Endothelium as a Target of the Risk Factors in Cardiovascular Disease |
|
|
227 | (16) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Oxidant Stress and Endothelial Function in Patients with Risk Factors for Atherosclerosis |
|
|
243 | (14) |
|
|
|
|
|
Endothelium-Derived Nitric Oxide: An Antiatherogenic Molecule |
|
|
257 | (12) |
|
|
|
|
|
|
|
|
|
Hormone Therapy and Nitric Oxide Bioactivity in Postmenopausal Women |
|
|
269 | (14) |
|
|
|
|
|
Clinical Trials Using Angiotensin-Converting Enzyme Inhibition to Alter Endothelial Dysfunction in Coronary Patients |
|
|
283 | (10) |
|
|
|
|
|
|
|
|
|
Nitrate Therapy in Cardiovascular Disease |
|
|
293 | (20) |
|
|
|
|
Index |
|
313 | |